Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Bisaga

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Journal of Substance Abuse Treatment|March 29, 2011
Comparison of clinical trial recruitment populations: treatment-seeking characteristics of opioid-, cocaine-, and cannabis-using participantsJohn J Mariani, Wendy Y Cheng, Adam Bisaga, et al.
Journal of Addictive Diseases|February 24, 2012
Comparison of substance use milestones in cannabis- and cocaine-dependent patientsJonathan T Horey, John J Mariani, Wendy Y Cheng, et al.
The American Journal on Addictions|March 30, 2018
Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategiesAdam Bisaga, Paolo Mannelli, Maria A Sullivan, et al.
The American Journal on Addictions|March 23, 2017
Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disordersArthur Robin Williams, Vincent Barbieri, Kaitlyn Mishlen, et al.
Addiction (Abingdon, England)|July 18, 2019
Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanismEdward V Nunes, Adam Bisaga, Evgeny Krupitsky, et al.
The American Journal of Drug and Alcohol Abuse|June 28, 2008
Antisocial behavioral syndromes in cocaine and cannabis dependenceJohn J Mariani, Jonathan Horey, Adam Bisaga, et al.
Drug and Alcohol Dependence|June 12, 2010
A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in periodAdam Bisaga, Efrat Aharonovich, Wendy Y Cheng, et al.
Journal of Addiction Medicine|December 21, 2023
Clinical Implications of the Relationship Between Naltrexone Plasma Levels and the Subjective Effects of Heroin in HumansFelipe Castillo, Hannah M Harris, Dania Lerman, et al.
The American Journal of Drug and Alcohol Abuse|November 28, 2006
Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcomeEfrat Aharonovich, Fatima Garawi, Adam Bisaga, et al.
Drug and Alcohol Dependence|July 6, 2013
Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade?Maria A Sullivan, Adam Bisaga, John J Mariani, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Journal of Substance Abuse Treatment|March 29, 2011
Comparison of clinical trial recruitment populations: treatment-seeking characteristics of opioid-, cocaine-, and cannabis-using participantsJohn J Mariani, Wendy Y Cheng, Adam Bisaga, et al.
Journal of Addictive Diseases|February 24, 2012
Comparison of substance use milestones in cannabis- and cocaine-dependent patientsJonathan T Horey, John J Mariani, Wendy Y Cheng, et al.
The American Journal on Addictions|March 30, 2018
Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategiesAdam Bisaga, Paolo Mannelli, Maria A Sullivan, et al.
The American Journal on Addictions|March 23, 2017
Long-term follow-up study of community-based patients receiving XR-NTX for opioid use disordersArthur Robin Williams, Vincent Barbieri, Kaitlyn Mishlen, et al.
Addiction (Abingdon, England)|July 18, 2019
Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanismEdward V Nunes, Adam Bisaga, Evgeny Krupitsky, et al.
The American Journal of Drug and Alcohol Abuse|June 28, 2008
Antisocial behavioral syndromes in cocaine and cannabis dependenceJohn J Mariani, Jonathan Horey, Adam Bisaga, et al.
Drug and Alcohol Dependence|June 12, 2010
A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in periodAdam Bisaga, Efrat Aharonovich, Wendy Y Cheng, et al.
Journal of Addiction Medicine|December 21, 2023
Clinical Implications of the Relationship Between Naltrexone Plasma Levels and the Subjective Effects of Heroin in HumansFelipe Castillo, Hannah M Harris, Dania Lerman, et al.
The American Journal of Drug and Alcohol Abuse|November 28, 2006
Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcomeEfrat Aharonovich, Fatima Garawi, Adam Bisaga, et al.
Drug and Alcohol Dependence|July 6, 2013
Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade?Maria A Sullivan, Adam Bisaga, John J Mariani, et al.
Pageof 10